Quebec – Montreal – Notre-Dame-de-Grâce
Corporation
www.alsclinic.com
Quebec
Montreal
Notre-Dame-de-Grâce
Corporation
active
ALS is a leading world-class CRO, offering solutions and Strategies that speed the product clinical development up. The testimonies about ALS Professionals reflect that Pharmaceuticals and Biotech trust and rely on ALS team. From the contents of the e-Library (http://www.alsclinic.com/english/e_library.html) it can be seen that each clinical study is conducted with a deep due diligence: it is designed and accomplished through an extensive review of available data, literature and guidance.
We conducted a variety of clinical studies driven by Ethics, Guidance and an extensive review of literature: - Phase 0 / Micro-dosing / First-in-man clinical trials
- Phase I (phase 1) clinical trials
- Bioavailability / Bioequivalence (BA/BE) clinical studies
- Nutraceutical clinical studies that we approach with rigor and specific guidance.
We have the expertise and the experience required for the following therapeutic areas but it is not limited to: - Allergies, Alzheimer, Cardiovascular, Depression, Diabetes, Epilepsy, Gastro-enterology, Hormones, Immunology, Oncology, Osteoporosis, Pain killers, Parkinson, Influenza virus vaccine.
- Natural health products, functional foods, probiotics.
- We are expert in the clinical development process of pharmaceutical drug products, biologics and medical devices.
- We help pharmaceuticals and biotech with input, support and writing of white papers: publication of study results, graphical presentations for press-release, business plan, funds raising, claim of SR - ED expenses of studies conducted with us, meetings with investors.
- Our expertise of Phase I clinical trials is an asset for complex bioequivalence clinical studies.
- We use an integrated and secured database and a-24/7 service for reliable and timely subject recruitment. The database contains healthy volunteers and a list of special populations. With our multilingual staff, the study subjects are well informed about the study rules, their rights and their obligations.
- Our clinical studies are conducted in collaboration with qualified GLP labs for OTC, Rx medications, Herbal - Natural Medicines. To view the validated analytical methods, click'' http://www.alsclinic.com/english/clinical_studies_services.html ''.
- Take a tour of our facilities: * http://www.alsclinic.com/english/bioequivalence_facility.html
* http://www.alsclinic.com/english/pharmacology_unit.html
Should you require any information, we'll be pleased to assisting you: call 1 514 750 6017 or send a message to: contact@alsclinic.com
Country of Ownership: Canada
Year Established: 2003
Exporting: Yes
Quality Certification: ISO 9001
Primary Industry (NAICS): 611710 - Educational Support Services
Alternate Industries (NAICS): 325410 - Pharmaceutical and Medicine Manufacturing
541611 - Administrative Management and General Management Consulting Services
541690 - Other Scientific and Technical Consulting Services
541990 - All Other Professional, Scientific and Technical Services
561410 - Document Preparation Services
Primary Business Activity: Services
Number of Employees: 70
Services:
Phase 0, phase i - ba/be clinical trials, Professional internship program, Forum of pharmaceutical discussions
Sector:
Unique Applications: ISO 9001 certification.
Key / Major Clients: - Pharmceutical Companies
- Biotech Companies
Success Stories: Read the testimonies about ALS Expertise and services: http://www.alsclinic.com/english/testimonies.html
Testimonial: Read the testimonies about ALS Expertise and services: http://www.alsclinic.com/english/testimonies.html
No associations
LandOfFree
Atlantic Life Sciences Inc. does not yet have a rating. At this time, there are no reviews or comments for this company.
If you have personal experience with Atlantic Life Sciences Inc., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Atlantic Life Sciences Inc. will most certainly appreciate the feedback.
Profile ID: LFCA-COD-O-13975